Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 10Unknown 9Recruiting 4Terminated 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Endocrine 1

Conditions

Rectal Neoplasms 2Colonic Neoplasms 2Neoplasms 1

Interventions

Oxaliplatin 197Bevacizumab 162Fluorouracil 155Capecitabine 137Gemcitabine 133Leucovorin 112pembrolizumab 99Cisplatin 93Drug Therapy 89Irinotecan 81Radiotherapy 73sintilimab 70durvalumab 65130-nm albumin-bound paclitaxel 65Paclitaxel 64Specimen Handling 62Cetuximab 61lenvatinib 59tislelizumab 58Nivolumab 55Magnetic Resonance Spectroscopy 55Folfox protocol 55Blood Specimen Collection 52atezolizumab 48Biopsy 46Surgical Procedures, Operative 40Taxes 38Albumin-Bound Paclitaxel 38Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × FOLFOXIRI protocol × Gastrointestinal × Clear all
NCT06242418 2024-12-12

REVISE

West China Hospital

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Colonic Neoplasms

NCT06575127 2024-08-28

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

Al-Azhar University

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT05201430 2022-03-04

RCNAC

Fudan University

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03671252 2019-01-23

Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation

Sun Yat-sen University

Phase 3 Recruiting
776 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡